Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Leiden, The Netherlands, March 20, 2014 - The Pediatric Praziquantel Consortium, launched in 2012 as an international non-profit public-private partnership, has announced that it has been awarded...
Read more about Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant
TOKYO, JAPAN and SAN FRANCISCO, CA – March 18, 2014 – Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced the submission of a supplemental New Drug Application...
Tokyo, Japan – March 19, 2014 – Astellas Pharma Inc. (“Astellas”; Tokyo: 4503; President and CEO: Yoshihiko Hatanaka) and Daiichi Sankyo Company, Limited (“Daiichi Sankyo,” President...
Read more about Astellas Pharma and Daiichi Sankyo Form Compound Library Sharing Partnership
Tokyo, February 28, 2014 – Astellas Pharma Inc. (Tokyo:4503, “Astellas”) announced today that the company has amended the License, Co-Development and Co-Promotion Agreement on isavuconazole...
Follow us
